A detailed history of Primecap Management CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Primecap Management CO holds 23,369,570 shares of BMY stock, worth $1.35 Billion. This represents 0.9% of its overall portfolio holdings.

Number of Shares
23,369,570
Previous 23,498,604 0.55%
Holding current value
$1.35 Billion
Previous $976 Million 23.92%
% of portfolio
0.9%
Previous 0.72%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$39.66 - $51.75 $5.12 Million - $6.68 Million
-129,034 Reduced 0.55%
23,369,570 $1.21 Billion
Q2 2024

Aug 09, 2024

BUY
$40.25 - $52.99 $9.06 Million - $11.9 Million
225,197 Added 0.97%
23,498,604 $976 Million
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $12.5 Million - $14.2 Million
-260,971 Reduced 1.11%
23,273,407 $1.26 Billion
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $145 Million - $173 Million
2,998,228 Added 14.6%
23,534,378 $1.21 Billion
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $23.8 Million - $26.6 Million
-410,895 Reduced 1.96%
20,536,150 $1.19 Billion
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $36.1 Million - $40.1 Million
-567,360 Reduced 2.64%
20,947,045 $1.34 Billion
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $22.5 Million - $25.5 Million
-342,160 Reduced 1.57%
21,514,405 $1.49 Billion
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $19.3 Million - $22.8 Million
-281,110 Reduced 1.27%
21,856,565 $1.57 Billion
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $9,623 - $5.69 Million
-74,030 Reduced 0.33%
22,137,675 $1.57 Billion
Q2 2022

Aug 11, 2022

SELL
$72.62 - $79.98 $11.5 Million - $12.7 Million
-158,670 Reduced 0.71%
22,211,705 $1.71 Billion
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $15.7 Million - $18.9 Million
255,920 Added 1.16%
22,370,375 $1.63 Billion
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $171 Million - $200 Million
3,195,680 Added 16.89%
22,114,455 $1.38 Billion
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $559,156 - $654,979
-9,450 Reduced 0.05%
18,918,775 $1.12 Billion
Q2 2021

Aug 10, 2021

SELL
$61.91 - $67.42 $19.1 Million - $20.8 Million
-308,740 Reduced 1.6%
18,928,225 $1.26 Billion
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $18 Million - $20.3 Million
-303,483 Reduced 1.55%
19,236,965 $1.21 Billion
Q4 2020

Feb 08, 2021

SELL
$57.74 - $65.43 $24.4 Million - $27.7 Million
-423,277 Reduced 2.12%
19,540,448 $1.21 Billion
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $37.9 Million - $42 Million
-660,070 Reduced 3.2%
19,963,725 $1.2 Billion
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $60.2 Million - $70.3 Million
-1,097,360 Reduced 5.05%
20,623,795 $1.21 Billion
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $51.1 Million - $74.2 Million
-1,100,700 Reduced 4.82%
21,721,155 $1.21 Billion
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $21 Million - $27.4 Million
426,180 Added 1.9%
22,821,855 $1.46 Billion
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $27 Million - $32.1 Million
632,340 Added 2.91%
22,395,675 $1.14 Billion
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $630,926 - $697,667
14,140 Added 0.07%
21,763,335 $987 Million
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $143 Million - $171 Million
3,171,821 Added 17.07%
21,749,195 $1.04 Billion
Q4 2018

Feb 12, 2019

SELL
$48.76 - $63.23 $16.1 Million - $20.8 Million
-329,320 Reduced 1.74%
18,577,374 $966 Million
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $47.6 Million - $53.7 Million
862,900 Added 4.78%
18,906,694 $1.17 Billion
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $81.5 Million - $102 Million
1,612,844 Added 9.82%
18,043,794 $999 Million
Q1 2018

May 14, 2018

BUY
$59.92 - $68.98 $592 Million - $681 Million
9,873,372 Added 150.56%
16,430,950 $1.04 Billion
Q4 2017

Feb 13, 2018

BUY
$59.94 - $65.35 $10.9 Million - $11.9 Million
182,678 Added 2.87%
6,557,578 $402 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $352 Million - $406 Million
6,374,900
6,374,900 $406 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.